CONTENTS:
- Examining the relationship between medical cannabis laws and cardiovascular deaths in the US. Abouk R., Adams S., p. 1-7.
- Effect of ageing and time since first heroin and cocaine use on mortality from external and natural causes in a Spanish cohort of drug users. Molist G., Brugal M.T., Barrio G., Mesías B., Bosque-Prous M., Parés-Badell O., et al., p. 8-16.
- The impact of OxyContin reformulation at the Sydney Medically Supervised Injecting Centre: Pros and cons. Jauncey M., Livingston M., Salmon A.M., Dietze P., p. 17-22.
- "Now drugs in Libya are much cheaper than food": A qualitative study on substance use among young Libyans in post-revolution Tripoli, Libya. Elamouri F.M., Musumari P.M., Techasrivichien T., Farjallah A., Elfandi S., Alsharif O.F., et al., p. 23-31.
- Role of recovery residences in criminal justice reform. Polcin D.L., p. 32-36.
- Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States. Davidson P.J., Lopez A.M., Kral A.H., p. 37-44.
- Spore forming bacteria infections and people who inject drugs: Implications for harm reduction. Dunleavy K., Munro A., Roy K., Hutchinson S., Palmateer N., Knox T., et al., p. 45-54.
- Is recovery from cannabis use problems different from alcohol and other drugs? Results from a national probability-based sample of the United States adult population. Kelly J.F., Greene M.C., Bergman B.G., p. 55-64.
- The three betrayals of the medical cannabis growing activist: From multiple victimhood to reconstruction, redemption and activism. Klein A., Potter G.R., p. 65-72.
- Making multiple 'online counsellings' through policy and practice: an evidence-making intervention approach. Savic M., Dilkes-Frayne E., Carter A., Kokanovic R., Manning V., Rodda S.N., et al., p. 73-82.
- Sheltering risks: Implementation of harm reduction in homeless shelters during an overdose emergency. Wallace B., Barber K., Pauly B., p. 83-89.
- Changes in public order after the opening of an overdose monitoring facility for people who inject drugs. Leon C., Cardoso L.J.P., Johnston S., Mackin S., Bock B., Gaeta J.M., p. 90-95.
- Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia. Tavitian-Exley I., Maheu-Giroux M., Platt L., Heimer R., Uuskula A., Levina O., et al., p. 96-105.
- 'You're repulsive': Limits to acceptable drunken comportment for young adults. MacLean S., Pennay A., Room R., p. 106-112.
- Hedging bets: Applying New Zealand's gambling machine regime to cannabis legalization. Caulkins J.P., p. 113-114.
- A "not-for-profit" regulatory model for legal recreational cannabis: Insights from the regulation of gaming machine gambling in New Zealand. Wilkins C., p. 115-122.
- Learning lessons: The need for effective evaluation of regulatory change. Wardle H., p. 123-124.
- The structured ambivalence of cannabis control in England & Wales. Brewster D., p. 125-132.